Atlas Trials

Metyrapone for Mild Autonomous Cortisol Secretion (MACS)

Clinical trial NCT06106295 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06106295
Sponsor
Mayo Clinic
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Autonomous Cortisol SecretionMild Autonomous Cortisol Secretion (MACS)
Start date
2023-12-19
Primary completion
2028-01-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.